POLYPEPTIDE MARKERS FOR THE DIAGNOSIS OF CANCERS, AND METHODS FOR THE DIAGNOSIS OF CANCERS USING THE SAME
    1.
    发明申请
    POLYPEPTIDE MARKERS FOR THE DIAGNOSIS OF CANCERS, AND METHODS FOR THE DIAGNOSIS OF CANCERS USING THE SAME 审中-公开
    用于诊断癌症的多肽标记,以及使用其诊断癌症的方法

    公开(公告)号:US20130261015A1

    公开(公告)日:2013-10-03

    申请号:US13850872

    申请日:2013-03-26

    CPC classification number: G01N33/6893 G01N33/57438

    Abstract: A method for diagnosing cancer using information on aberrant glycosylation of glycoproteins, which is related with cancer progression. More particularly, the present invention relates to a peptide marker for cancer diagnosis and a method for diagnosing cancer using the peptide marker, wherein glycoproteins aberrantly glycosylated due to cancer incidence and progression is isolated using lectin; and marker peptides generated by hydrolysis or the glycoproteins isolated by the lectin is selected and quantified.

    Abstract translation: 使用与癌症进展相关的糖蛋白异常糖基化的信息诊断癌症的方法。 更具体地,本发明涉及用于癌症诊断的肽标记物和使用肽标记物诊断癌症的方法,其中使用凝集素分离由于癌症发生和进展而异常糖基化的糖蛋白; 选择并定量通过水解产生的标记肽或由凝集素分离的糖蛋白。

Patent Agency Ranking